David Happel

Insider Reports History

Entity
Individual
Location
7 Hamilton Landing, Suite 100, Novato, CA
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Happel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sagimet Biosciences Inc. President & CEO, Director Series A Common Stock 639K $3.37M $5.27 Mar 26, 2024 Direct
Sagimet Biosciences Inc. President & CEO, Director Stock Option (Right to Buy) 1.01M Jul 18, 2023 Direct

Insider Reports Filed by David Happel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGMT Sagimet Biosciences Inc. Mar 26, 2024 1 $63.7K 4 Mar 28, 2024 President & CEO, Director
SGMT Sagimet Biosciences Inc. Dec 7, 2023 1 $6.56K 4 Dec 8, 2023 President & CEO, Director
SGMT Sagimet Biosciences Inc. Nov 17, 2023 1 $0 4 Nov 21, 2023 President & CEO, Director
SGMT Sagimet Biosciences Inc. Nov 16, 2023 1 $1.39K 4 Nov 20, 2023 President & CEO, Director
SGMT Sagimet Biosciences Inc. Jul 18, 2023 2 $0 4 Jul 20, 2023 President & CEO, Director
SGMT Sagimet Biosciences Inc. Jul 13, 2023 0 $0 3 Jul 13, 2023 President & CEO, Director